YpsoDose is a patch injector for large volumes. When developing YpsoDose, we focus on user-friendliness as we do with all our injection systems. The latest user studies have confirmed how easy YpsoDose is to use.
Several customers have recently launched their autoinjectors based on our YpsoMate platform product technology on the market. Customers value the fast product customisation as well as the individual design possibilities. End users appreciate its user-friendliness.
Digitisation opens the door for new products and new possibilities in the diabetes therapy management. Due to digitisation, patients are gaining knowledge and independence and therefore their demands increase. As a result, the patient-doctor relationship is undergoing change.
The number of Type 1 diabetics using old insulin pumps without secure communication interfaces to build their own “Closed Loop” system is growing steadily. The so-called “loopers” are thus sending a clear signal to manufacturers and showing what is in demand for insulin pump therapy.
In the interview she explains the consequences of digitisation for the healthcare system. Classical systems and processes are breaking up and need to be redefined. But what exactly does digitisation do to us?